SRPT vs WTW · rev $1.13B vs P/E 15, rev $4.88B
Sarepta Therapeutics Inc (SRPT) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Latest reported WTW revenue for 2026-06-30 was $4.88B. Net income was $526.0M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
SRPT currently screens at market cap $2.34B. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the SRPT and WTW stock pages for the full models.
Not investment advice.